Results 141 to 150 of about 9,980 (152)

Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D 179 Y Substitution in the KPC-2 β-Lactamase

Antimicrobial Agents and Chemotherapy, 2017
Michel Arthur, Fabrice Compain
exaly  

Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2017
Martin Rottman, Benjamin Davido, Christine Lawrence   +2 more
exaly  

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity

Antimicrobial Agents and Chemotherapy, 2017
Shana R Leopold, Peera Hemarajata, Andrew Kasarskis   +2 more
exaly  

Pharmacological aspects and spectrum of action of ceftazidime–avibactam: a systematic review

Infection, 2017
Felipe Tuon, Tuon Felipe FRANCISCO
exaly  

Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value

Journal of Chemotherapy, 2014
Greg Stone, Helio Sader, Wright Nichols   +2 more
exaly  

In vitropharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms

Journal of Antimicrobial Chemotherapy, 2016
Sherwin K B Sy, Hartmut Derendorf, Derendorf Hartmut   +2 more
exaly  

In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015

Antimicrobial Agents and Chemotherapy, 2017
Patricia Bradford, James Karlowsky, Meredith Hackel   +2 more
exaly  

Randomized, placebo‐controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime–avibactam or ceftaroline fosamil–avibactam

Journal of Clinical Pharmacology, 2014
Shampa Das
exaly  

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical Infectious Diseases, 2016
Greg Stone, Florian Wagenlehner, Jack Sobel   +2 more
exaly  

Avibactam/ceftazidime

Reactions Weekly, 2018
openaire   +1 more source